TELA Bio, Inc.·4

Jan 29, 7:14 PM ET

Murphy Peter C. 4

4 · TELA Bio, Inc. · Filed Jan 29, 2020

Insider Transaction Report

Form 4
Period: 2020-01-27
Murphy Peter C.
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-27+60,00060,000 total
    Exercise: $15.50Exp: 2030-01-27Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The option vests 25% on January 27, 2021, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT